Prosecution Insights
Prosecution Insights
13 pending office actions • 5 art units • 11 examiners • 0 of 13 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (15%) |
| §103 only | 2 (15%) |
| §102 only | 1 (8%) |
| §112 only | 1 (8%) |
| Double-patenting only | 3 (23%) |
| Double-patenting + other | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIS, DOUGLAS M | 2 | 82.4% | +19.5% |
| KALLAL, ROBERT JAMES | 2 | 60.6% | +33.7% |
| DAVIS, BRIAN J | 1 | 84.8% | -4.1% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.3% | +8.0% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +20.3% |
| ROBINSON, MIKHAIL O'DONNEL | 1 | 58.9% | +41.5% |
| HASTINGS, ALISON AZAR | 1 | 63.3% | +40.3% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| LADD, CAROLYN LOUISE | 1 | 57.0% | +47.9% |
| LUO, JAMMY NMN | 1 | — | — |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18928814 | BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES | DAVIS, BRIAN J | — |
| 18708686 | SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF | WILLIS, DOUGLAS M | — |
| 18702772 | METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF | WILLIS, DOUGLAS M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17596888 | SYNTHETIC BIOLOGICAL CHARACTERISTIC GENERATOR BASED ON REAL BIOLOGICAL DATA SIGNATURES | KALLAL, ROBERT JAMES | 25d overdue |
| 17835167 | ADVERSARIAL FRAMEWORK FOR MOLECULAR CONFORMATION SPACE MODELING IN INTERNAL COORDINATES | LUO, JAMMY NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17596888 | SYNTHETIC BIOLOGICAL CHARACTERISTIC GENERATOR BASED ON REAL BIOLOGICAL DATA SIGNATURES | KALLAL, ROBERT JAMES | 25d overdue |
| 18837847 | MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | — |
| 18837846 | MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF | ROBINSON, MIKHAIL O'DONNEL | — |
| 18708686 | SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF | WILLIS, DOUGLAS M | — |
| 18705742 | SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | HASTINGS, ALISON AZAR | — |
| 18704366 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF | O DELL, DAVID K | — |
| 18702772 | METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF | WILLIS, DOUGLAS M | — |
| 18547190 | ANALOGS FOR THE TREATMENT OF DISEASE | LADD, CAROLYN LOUISE | — |
| Art Unit | Apps |
|---|---|
| 1686 | 2 |
| 1629 | 1 |
| 1622 | 1 |
| 2146 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18928814 | BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES | DAVIS, BRIAN J | — | DP | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18841639 | DIACYLGLYCEROL KINASE (DGK) ALPHA INHIBITORS AND USES THEREOF | SHTERENGARTS, SAMANTHA L | — | §102DP | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18837847 | MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | — | §103DP | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18837846 | MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF | ROBINSON, MIKHAIL O'DONNEL | — | §103 | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18708686 | SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF | WILLIS, DOUGLAS M | — | §112Other | Non-Final OA | — | Pending | May 09, 2024 |
| 18705742 | SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | HASTINGS, ALISON AZAR | 1629 | §103§112DP | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18704366 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF | O DELL, DAVID K | — | DP | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18702772 | METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF | WILLIS, DOUGLAS M | — | §112DP | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18547190 | ANALOGS FOR THE TREATMENT OF DISEASE | LADD, CAROLYN LOUISE | 1622 | §102 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18164160 | LOCAL STEPS IN LATENT SPACE AND DESCRIPTORS-BASED MOLECULES FILTERING FOR CONDITIONAL MOLECULAR GENERATION | KALLAL, ROBERT JAMES | 2146 | §103 | Non-Final OA | — | Pending | Feb 03, 2023 |
| 17835167 | ADVERSARIAL FRAMEWORK FOR MOLECULAR CONFORMATION SPACE MODELING IN INTERNAL COORDINATES | LUO, JAMMY NMN | 1686 | §101§103 | Final Rejection | — | Pending | Jun 08, 2022 |
| 17596888 | SYNTHETIC BIOLOGICAL CHARACTERISTIC GENERATOR BASED ON REAL BIOLOGICAL DATA SIGNATURES | KALLAL, ROBERT JAMES | 1685 | §101§112 | Non-Final OA | 25d overdue | Pending | Dec 20, 2021 |
| 17479892 | METHYLATION DATA SIGNATURES OF AGING AND METHODS OF DETERMINING A METHYLATION AGING CLOCK | VANNI, GEORGE STEVEN | 1686 | DP | Non-Final OA | — | Pending | Sep 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial